Expert committee recommends Covaxin for children in 2-18 age group

New Delhi: The Subject Expert Committee (SEC) has given a recommendation to Drugs Controller General of India (DCGI) for the use of Bharat Biotech’s Covaxin on children between two and 18 years of age. With the administration of 65,86,092 COVID-19 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage exceeded 95.89 crores, informed the health ministry said on Tuesday.

As per provisional reports, till 7 am today, 95,89,78,049 vaccine doses have been administered so far through 93,66,392 sessions. Of the total, 1,03,75,424 health care workers received the first dose and 90,36,583 second vaccine doses; 1,83,59,259 front line workers were administered the first dose and 1,53,98,857 vaccine doses given as the second dose to front line workers.

According to the health ministry, 38,68,20,261 vaccine doses were administered as the first dose and 10,40,73,546 vaccine doses were given as the second dose in the age group 18-44 years.

Also, in the age group of 45-59 years, 16,61,56,424 people have received the first dose and 8,38,76,362 have received the second dose whereas 10,48,69,202 vaccine doses were administered as first dose and 6,00,12,131 vaccine doses given as the second dose to the people over 60 years.